Skip to content
008613264500477
info@chinacartcell.com
China CAR-T Cell
Help patients with CAR-T Matters!
Menu
Home
CAR-T
Basic Knowledge
Who qualifies
CAR-T Efficacy
Why China CAR-T
Other Things
Hospitals
Services
News
Contact
CAR-T Efficacy
CAR-T Clinical Data(CR) from the hospitals in China
B-Cell Acute Lymphoblastic Leukemia: 80-90%
T-Cell Acute Lymphoblastic Leukemia: 90-99%
B-Cell Lymphoma: 70-80%
Multiple Myeloma: 70-80%
Clinical Reports
Patient Stories
Search
Search
Latest Articles
Macau’s first CAR-T cell therapy center launched
The significance of CAR-T therapy in treatment of blood tumors
A 70-year-old man with multiple myeloma saved by CAR-T therapy
Newly Approved CAR-T Around USD140,000
Precise CAR-T cell therapy works for R/R acute lymphoblastic leukemia
Latest Comments
Language»
WhatsApp us